81 related articles for article (PubMed ID: 12205713)
1. Symptoms of schizophrenia and neurocognitive test performance.
Shean G; Burnett T; Eckman FS
J Clin Psychol; 2002 Jul; 58(7):723-31. PubMed ID: 12205713
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
4. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study.
Kurtz MM; Moberg PJ; Ragland JD; Gur RC; Gur RE
Schizophr Bull; 2005 Jan; 31(1):167-74. PubMed ID: 15888434
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological frontal impairments and negative symptoms in schizophrenia.
Martino DJ; Bucay D; Butman JT; Allegri RF
Psychiatry Res; 2007 Aug; 152(2-3):121-8. PubMed ID: 17507100
[TBL] [Abstract][Full Text] [Related]
6. [Learning potential and cognitive remediation in schizophrenia].
Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
[TBL] [Abstract][Full Text] [Related]
7. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics.
Sota TL; Heinrichs RW
Compr Psychiatry; 2004; 45(5):415-21. PubMed ID: 15332206
[TBL] [Abstract][Full Text] [Related]
8. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
9. Card-sort performance and syndromes of schizophrenia.
Rowe EW; Shean G
Genet Soc Gen Psychol Monogr; 1997 May; 123(2):197-209. PubMed ID: 9204545
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Gibel A; Ritsner MS
Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
[TBL] [Abstract][Full Text] [Related]
11. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
12. Stability of set-shifting and planning abilities in patients with schizophrenia.
Tyson PJ; Laws KR; Roberts KH; Mortimer AM
Psychiatry Res; 2004 Dec; 129(3):229-39. PubMed ID: 15661316
[TBL] [Abstract][Full Text] [Related]
13. Parsing schizophrenia with neurocognitive tests: evidence of stability and validity.
Heinrichs RW; Ruttan L; Zakzanis KK; Case D
Brain Cogn; 1997 Nov; 35(2):207-24. PubMed ID: 9356162
[TBL] [Abstract][Full Text] [Related]
14. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
[TBL] [Abstract][Full Text] [Related]
15. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
[TBL] [Abstract][Full Text] [Related]
16. Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms.
Barch DM; Carter CS; MacDonald AW; Braver TS; Cohen JD
J Abnorm Psychol; 2003 Feb; 112(1):132-43. PubMed ID: 12653421
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological subtyping of schizophrenia.
Ilonen T; Taiminen T; Karlsson H; Lauerma H; Leinonen KM; Wallenius E; Salokangas RK
Psychiatry Res; 2004 Dec; 129(2):191-9. PubMed ID: 15590046
[TBL] [Abstract][Full Text] [Related]
18. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains.
Norman RM; Malla AK; Manchanda R; Townsend L
Acta Psychiatr Scand; 2005 Jul; 112(1):30-9. PubMed ID: 15952943
[TBL] [Abstract][Full Text] [Related]
19. Premorbid IQ and schizophrenia. Increasing cognitive reduction by episodes.
Eberhard J; Riley F; Levander S
Eur Arch Psychiatry Clin Neurosci; 2003 Apr; 253(2):84-8. PubMed ID: 12799746
[TBL] [Abstract][Full Text] [Related]
20. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
